Natural products modulate NLRP3 in ulcerative colitis

Natural products modulate NLRP3 in ulcerative colitis

Ulcerative colitis (UC) is a clinically common, progressive, devastating, chronic inflammatory disease of the intestine that is recurrent and difficult to treat. Nod-like receptor protein 3 (NLRP3) is a protein complex composed of multiple proteins whose formation activates cysteine aspartate protea...

Full description

Bibliographic Details
Main Authors:	Jia-Chen Xue, Shuo Yuan, Xiao-Ting Hou, Huan Meng, Bao-Hong Liu, Wen-Wen Cheng, Ming Zhao, Hong-Ben Li, Xue-Fen Guo, Chang Di, Min-Jie Li, Qing-Gao Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-10-01
Series:	Frontiers in Pharmacology
Subjects:	Chinese medicine inflammatory bowel disease NLRP3 traditional natural products ulcerative colitis
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1265825/full

Similar Items

The role and mechanism of flavonoid herbal natural products in ulcerative colitis
by: Jia-Chen Xue, et al.
Published: (2023-02-01)

KLF4 interacts with TXNIP to modulate the pyroptosis in ulcerative colitis via regulating NLRP3 signaling
by: Yuan Chen, et al.
Published: (2024-02-01)

Gallic acid ameliorates dextran sulfate sodium-induced ulcerative colitis in mice via inhibiting NLRP3 inflammasome
by: Tian-Yuan Yu, et al.
Published: (2023-01-01)

Vitamin D3 alleviates inflammation in ulcerative colitis by activating the VDR-NLRP6 signaling pathway
by: Hongliang Gao, et al.
Published: (2023-02-01)

Treatment of Ulcerative Colitis by Cationic Liposome Delivered NLRP3 siRNA
by: Huang J, et al.
Published: (2023-08-01)

Armillariella tabescens methanol extract ameliorates ulcerative colitis via inhibiting TLR4/NF-κB and NLRP3 activation and mediating intestinal barrier integrity
by: Wen-Na Zhang, et al.
Published: (2022-12-01)

Ulcerative colitis: Al-gassim experience
by: Contractor Qais, et al.
Published: (2004-01-01)

Forsythia suspensa (Thunb.) Vahl extract ameliorates ulcerative colitis via inhibiting NLRP3 inflammasome activation through the TLR4/MyD88/NF‐κB pathway
by: Xiao Tong, et al.
Published: (2023-11-01)

Is Infection Associated With Ulcerative Colitis Activity?
by: Ayoung Lee, et al.
Published: (2024-03-01)

Enteric infections complicating ulcerative colitis
by: Dejan Micic, et al.
Published: (2018-07-01)

New developments in ulcerative colitis: latest evidence on management, treatment, and maintenance
by: Kartikeya Tripathi, et al.
Published: (2019-04-01)

Ulcerative Colitis and Neopterin: Related?
by: Beşir Kesici, et al.
Published: (2019-04-01)

Oral intake of titanium dioxide nanoparticles affect the course and prognosis of ulcerative colitis in mice: involvement of the ROS-TXNIP-NLRP3 inflammasome pathway
by: Shumin Duan, et al.
Published: (2023-06-01)

Ulcerative Colitis and Acute Severe Ulcerative Colitis Patients Are Overlooked in Infliximab Population Pharmacokinetic Models: Results from a Comprehensive Review
by: Alix Démaris, et al.
Published: (2022-09-01)

Anti-integrin treatment as an effective alternative for a patient with ulcerative colitis
by: Ewa Biegańska, et al.
Published: (2022-12-01)

Ulcerative colitis in infancy: our results
by: Leili Mohajerzadeh, et al.
Published: (2016-08-01)

Contradictory Effects of NLRP3 Inflammasome Regulatory Mechanisms in Colitis
by: Kohei Wagatsuma, et al.
Published: (2020-10-01)

Oral manifestation of ulcerative colitis
by: Đuričković Aleksa, et al.
Published: (2022-01-01)

A Schistosoma Colitis Case Misdiagnosed as Ulcerative Colitis in a Non-Endemic Area: A Case Report
by: Çağatay Ak, et al.
Published: (2022-09-01)

Editorial: Recent advances and new biomarkers in ulcerative colitis
by: Tsvetelina Velikova, et al.
Published: (2023-05-01)

miRNA-Based Potential Biomarkers and New Molecular Insights in Ulcerative Colitis
by: Jing Zhou, et al.
Published: (2021-07-01)

The potential mechanism of huazhuojiedu decoction in the treatment of ulcerative colitis based on network pharmacology and experimental validation
by: Xuemei Jia, et al.
Published: (2022-10-01)

The Role of AMPK Signaling in Ulcerative Colitis
by: Yuan Y, et al.
Published: (2023-12-01)

Optimal Management of Acute Severe Ulcerative Colitis (ASUC): Challenges and Solutions
by: Holvoet T, et al.
Published: (2021-03-01)

Severe de novo Ulcerative Colitis following Ixekizumab Therapy
by: Jobin Philipose, et al.
Published: (2018-10-01)

Role of Toll-Like Receptor 5 in the Development of Ulcerative Colitis
by: A Falah Alshimerry, et al.
Published: (2021-12-01)

Association between aortic aneurysm and ulcerative colitis: A nationwide taiwanese retrospective cohort study
by: Chih-Jen Yang, et al.
Published: (2019-01-01)

Low Weight Polysaccharide of <i>Hericium erinaceus</i> Ameliorates Colitis via Inhibiting the NLRP3 Inflammasome Activation in Association with Gut Microbiota Modulation
by: Yilin Ren, et al.
Published: (2023-02-01)

Role of microRNAs in the Pathophysiology of Ulcerative Colitis
by: Takahiko Toyonaga, et al.
Published: (2021-12-01)

Second Korean Guideline for the Management of Ulcerative Colitis
by: Chang Hwan Choi, et al.
Published: (2017-01-01)

Pulmonary Function in Ulcerative Colitis
by: A.H. Faghihi-Kashani, et al.
Published: (2008-02-01)

Rapid Induction and Maintenance of Remission in Refractory Ulcerative Colitis with Ustekinumab
by: An-Yu Chen, et al.
Published: (2019-09-01)

Curcumin-QingDai Combination as Treatment for Moderate-Severe Ulcerative Colitis
by: Shomron Ben-Horin, et al.
Published: (2022-09-01)

A Novel Neutrophil-Based Biomarker to Monitor Disease Activity and Predict Response to Infliximab Therapy in Patients With Ulcerative Colitis
by: Zhou Zhou, et al.
Published: (2022-04-01)

Schisandrin protects against ulcerative colitis by inhibiting the SGK1/NLRP3 signaling pathway and reshaping gut microbiota in mice
by: Xiaohu Wang, et al.
Published: (2023-09-01)

The role of Trans-abdominal Ultrasound in Assessing Disease Activity and Severity in Ulcerative Colitis
by: Ragab Mahmoud Ragab, et al.
Published: (2021-01-01)

Transplantation of bacteriophages from ulcerative colitis patients shifts the gut bacteriome and exacerbates the severity of DSS colitis
by: Anshul Sinha, et al.
Published: (2022-07-01)

Arthritis Associated with Ulcerative Colitis: Our Experience in Palermo
by: A Geraci, et al.
Published: (2009-01-01)

SOME ASPECTS OF TREATMENT FOR LEFT-SIDED ULCERATIVE COLITIS
by: P. A. Makarchuk, et al.
Published: (2016-02-01)

Serum Concentrations of Trace Elements in Patients with Ulcerative Colitis
by: Hamidreza Joshaghani, et al.
Published: (2018-08-01)